221 related articles for article (PubMed ID: 17434339)
1. Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression.
Morsica G; Bagaglio S; Ghezzi S; Lodrini C; Vicenzi E; Santagostino E; Gringeri A; Cusini M; Carminati G; Bianchi G; Galli L; Lazzarin A; Poli G
J Clin Virol; 2007 Jun; 39(2):82-6. PubMed ID: 17434339
[TBL] [Abstract][Full Text] [Related]
2. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.
Yoo TW; Donfield S; Lail A; Lynn HS; Daar ES;
J Infect Dis; 2005 Jan; 191(1):4-10. PubMed ID: 15592996
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.
Goedert JJ; Hatzakis A; Sherman KE; Eyster ME;
J Infect Dis; 2001 Nov; 184(9):1202-5. PubMed ID: 11598846
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
Nattermann J; Vogel M; Nischalke HD; Danta M; Ahlenstiel G; Michalk M; Sauerbruch T; Rockstroh JK; Spengler U;
AIDS; 2008 Jul; 22(11):1287-92. PubMed ID: 18580607
[TBL] [Abstract][Full Text] [Related]
9. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
[TBL] [Abstract][Full Text] [Related]
10. Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.
Lapadula G; Torti C; Paraninfo G; Castelnuovo F; Uccelli MC; Costarelli S; Ladisa N; Maserati R; Di Pietro M; De Silvestri A; Tinelli C; Puoti M; Carosi G;
Antivir Ther; 2006; 11(4):521-7. PubMed ID: 16856626
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes.
Agwale SM; Tanimoto L; Womack C; Odama L; Leung K; Duey D; Negedu-Momoh R; Audu I; Mohammed SB; Inyang U; Graham B; Ziermann R
J Clin Virol; 2004 Dec; 31 Suppl 1():S3-6. PubMed ID: 15567088
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
Daar ES; Lynn H; Donfield S; Gomperts E; O'Brien SJ; Hilgartner MW; Hoots WK; Chernoff D; Arkin S; Wong WY; Winkler CA;
J Infect Dis; 2001 Feb; 183(4):589-95. PubMed ID: 11170984
[TBL] [Abstract][Full Text] [Related]
14. HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections.
Ríos-Olivares E; Yamamura Y; Gómez MA; Guzmán L; Rodríguez N; Fernández D; Hunter Mellado R
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1017-24. PubMed ID: 11785651
[TBL] [Abstract][Full Text] [Related]
15. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
16. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
[TBL] [Abstract][Full Text] [Related]
17. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
18. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis C infection in HIV patients using a rapid one-step test strip kit.
Akinbami AA; Oshinaike OO; Adeyemo TA; Adediran A; Oshikomaiya BI; Ismail KA
Nig Q J Hosp Med; 2010; 20(3):144-6. PubMed ID: 21033324
[TBL] [Abstract][Full Text] [Related]
20. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
